Drugs / PF-07265807
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04458259 | Sep 2020 → Nov 2024 | metastatic malignant neoplasm | Pfizer | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-07265807 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04458259 ↗ |
| Modality | Small molecule | — CHEMBL6060997 ↗ |